JERUSALEM, March 27 (Xinhua) -- An Israeli-led research team has developed a potential new treatment for head and neck cancer (HNC), using a targeted drug and immunotherapy, Ben Gurion University (BGU) in southern Israel announced on Sunday.
The findings, co-authored by Israeli, Chinese, French, German and U.S. researchers, were published in the Journal for ImmunoTherapy of Cancer on Sunday.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
